A phase II, open‐label evaluation of cysteamine tolerability in patients with Huntington's disease. Issue 2 (5th December 2014) - Prundean, Adriana; Youssov, Katia; Humbert, Sandrine; Bonneau, Dominique; Verny, Christophe; Stacy (Chair), Mark; Lang, Anthony; Napier, Celeste; Samuel, Michael; Strafella, Antonio; Weintraub, Daniel